Ken Griffin ROCKET PHARMACEUTICALS INC Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025
Number of Shares
314,842
Previous 317,303 0.78%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-2,461 Reduced 0.78%
314,842 $0
Q1 2025

May 15, 2025
SELL
N/A
-20,301 Reduced 6.01%
317,303 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-5,793 Reduced 1.69%
337,604 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-27,202 Reduced 7.34%
343,397 $0
Q2 2024

Aug 14, 2024
BUY
N/A
5,776 Added 1.58%
370,599 $0
Q1 2024

May 15, 2024
BUY
N/A
64,523 Added 21.49%
364,823 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-24,549 Reduced 7.56%
300,300 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-27,965 Reduced 7.93%
324,849 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-4,636 Reduced 1.3%
352,814 $0
Q1 2023

May 15, 2023
BUY
N/A
357,450 New
357,450 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email